Michael J. Daugherty, is the President of LabMD, an Atlanta-based clinical and anatomic medical laboratory as well as CEO of AnyLabTestNow in Virginia. LabMD specializes in analysis and diagnosis of blood, urine, and tissue specimens for cancers, micro-organisms and tumor markers. He has 20 years experience in diagnostic laboratory medicine. He is author of The Devil Inside the Beltway: The Shocking Expose of the US Government’s Surveillance and Overreach Into Cybersecurity, Medicine and Small Business. U.S. health officials and drugmakers expect to start producing potential coronavirus vaccine doses by the end of the summer, a senior administration official said Monday. The U.S. is aiming to deliver 300 million doses of a vaccine for Covid-19 by early 2021. The manufacturing process is already underway even though they aren’t sure which vaccine, if any, will work, a senior Trump administration official told reporters on a conference call Monday. He said they are already buying equipment, securing the manufacturing sites and, in some cases, acquiring the raw materials. “Exactly when the vaccine materials will be in production and manufacturing? It’s probably four to six weeks away,” the official said on the call, which was hosted by the Department of Health and Human Services. “But we will be actively manufacturing by the end of the summer.”
Sign up (on the right side) for the instant free Financial Survival Toolkit and free weekly newsletter.